0000899243-18-025551.txt : 20180928
0000899243-18-025551.hdr.sgml : 20180928
20180928204333
ACCESSION NUMBER: 0000899243-18-025551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180926
FILED AS OF DATE: 20180928
DATE AS OF CHANGE: 20180928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassidy Sean A
CENTRAL INDEX KEY: 0001421914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38672
FILM NUMBER: 181095651
MAIL ADDRESS:
STREET 1: 322 EAST MAIN STREET
CITY: BRANFORD
STATE: CT
ZIP: 06405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC
CENTRAL INDEX KEY: 0001655759
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472566120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 WINCHESTER COMPANY, LLC
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-535-1456
MAIL ADDRESS:
STREET 1: 395 WINCHESTER COMPANY, LLC
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-26
0
0001655759
ARVINAS HOLDING COMPANY, LLC
ARVN
0001421914
Cassidy Sean A
C/O ARVINAS, INC.
5 SCIENCE PARK, 395 WINCHESTER AVE.
NEW HAVEN
CT
06511
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
16.00
2018-09-26
4
A
0
1980
0.00
A
2028-09-25
Common Stock
1980
1980
D
Stock Option (right to buy)
16.00
2018-09-26
4
A
0
31710
0.00
A
2028-09-25
Common Stock
31710
31710
D
Stock Option (right to buy)
16.00
2018-09-26
4
A
0
15160
0.00
A
2028-09-25
Common Stock
15160
15160
D
Stock Option (right to buy)
16.00
2018-09-26
4
A
0
5200
0.00
A
2028-09-25
Common Stock
5200
5200
D
Stock Option (right to buy)
16.00
2018-09-26
4
A
0
81770
0.00
A
2028-09-25
Common Stock
81770
81770
D
Stock Option (right to buy)
16.00
2018-09-26
4
A
0
27330
0.00
A
2028-09-25
Common Stock
27330
27330
D
This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant.
This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant.
This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020.
This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.
This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.
This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.
/s/ Matthew Batters, as attorney-in-fact for Sean A Cassidy
2018-09-28